Difference in soft tissue response between immediate and delayed delivery suggests a new mechanism for recombinant human bone morphogenetic protein 2 action in large segmental bone defects

Tissue Engineering - Part A

Volumn 18, Issue 5-6, 2012, Pages 665-675

  Hussein, Khaled A ^a,b   Zakhary, Ibrahim E ^b   Elawady, Ahmed R ^b   Emam, Hany A ^b   Sharawy, Mohamed ^b   Baban, Babak ^b   Akeel, Sara ^b   Al Shabrawey, Mohamed ^b,c   Elsalanty, Mohammed E ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENDOTHELIAL CELLS; POLYMERASE CHAIN REACTION; PROTEINS; TISSUE;

BONE MORPHOMETRY; BONE REGENERATION; COLLAGEN SPONGE; COLOCALIZATION; CRANIOFACIAL DEFECTS; DIRECT MEASUREMENT; HUMAN BONE MORPHOGENETIC PROTEIN; LOW DENSITY LIPOPROTEINS; MRNA EXPRESSION; NEW MECHANISMS; OSTEOGENIC RESPONSE; PHYSICAL DIMENSIONS; REAL-TIME QUANTITATIVE PCR; RHBMP-2; SEGMENTAL BONE DEFECT; SOFT TISSUE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

DEFECTS;

CANIS FAMILIARIS;

ACETYL LOW DENSITY LIPOPROTEIN; ACETYL-LDL; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; LOW DENSITY LIPOPROTEIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE REGENERATION; CRANIOFACIAL MALFORMATION; DISEASE MODEL; DOG; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; MANDIBLE FRACTURE; METABOLISM; PATHOLOGY; PERIOSTEUM; TIME;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CRANIOFACIAL ABNORMALITIES; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MANDIBULAR FRACTURES; PERIOSTEUM; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857888768     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0148     Document Type: Article

References (41)

1. Cancedda, R., Giannoni, P., and Mastrogiacomo, M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28, 4240, 2007.
2. McKay, W.F., Peckham, S.M., and Badura, J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31, 729, 2007.
3. Carter, T.G., Brar, P.S., Tolas, A., and Beirne, O.R. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 66, 1417, 2008.
4. Herford, A.S., and Boyne, P.J. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66, 616, 2008.
5. Van Gemert, J.T.M., van Es, R.J.J., Van Cann, E.M., and Koole, R. Nonvascularized bone grafts for segmental reconstruction of the mandible-a reappraisal. J Oral Maxillofac Surg 67, 1446, 2009.
6. Bell, R.B., and Gregoire, C. Reconstruction of mandibular continuity defects using recombinant human bone morphogenetic protein 2: a note of caution in an atmosphere of exuberance. J Oral Maxillofac Surg 67, 2673, 2009.
7. Cantu, G., Bimbi, G., Colombo, S., Riccio, S., Squadrelli, M., Napoli, U., et al. Autologous freeze-treated bone for mandibular reconstruction after malignant tumor resection: a study of 72 patients. Am J Otolaryngol 30, 383, 2009.
8. Marx, R.E. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. J Oral Maxillofac Surg 67, 107, 2009.
9. Elsalanty, M.E., and Genecov, D.G. Bone grafts in craniofacial surgery. Craniomaxillofacial Trauma Reconstr 2, 125, 2009.
10. Malizos, K.N., and Papatheodorou, L.K. The healing potential of the periosteum molecular aspects. Injury 36 Suppl 3, S13, 2005.
11. Park, S.H., Silva, M., Bahk, W.J., McKellop, H., and Lieberman, J.R. Effect of repeated irrigation and debridement on fracture healing in an animal model. J Orthop Res 20, 1197, 2002.
12. Mizuno, K., Mineo, K., Tachibana, T., Sumi, M., Matsubara, T., and Hirohata, K. The osteogenetic potential of fracture hematoma-subperiosteal and intramuscular transplantation of the hematoma. J Bone Joint Surg Br 72, 822, 1990.
13. Seeherman, H., Wozney, J., and Li, R. Bone morphogenetic protein delivery systems. Spine 27, S16, 2002.
14. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2, 595, 1987.
15. El-Awady, A.R., Messer, R.L.W., Gamal, A.Y., Sharawy, M.M., Wenger, K.H., and Lapp, C.A. Periodontal ligament fibroblasts sustain destructive immune modulators of chronic periodontitis. J Periodontol 81, 1324, 2010.
16. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402, 2001.
17. Yuan, J.S., Reed, A., Chen, F., and Stewart, C.N., Jr. Statistical analysis of real-time PCR data. BMC Bioinforma 7, 85, 2006.
18. Elsalanty, M.E., Zakhary, I., Akeel, S., Benson, B., Mulone, T., Triplett, G.R., et al. Reconstruction of canine mandibular bone defects using a bone transport reconstruction plate. Ann Plast Surg 63, 441, 2009.
19. Huh, J.Y., Choi, B.H., Kim, B.Y., Lee, S.H., Zhu, S.J., and Jung, J.H. Critical size defect in the canine mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100, 296, 2005.
20. Toriumi, D.M., O'Grady, K., Horlbeck, D.M., Desai, D., and Turek, T.J. Mandibular reconstruction using bone morphogenetic protein 2: long-term follow-up in a canine model. Laryngoscope 109, 1481, 1999.
21. Jones, A.A., Buser, D., Schenk, R., Wozney, J., and Cochran, D.L. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 77, 1184, 2006.
22. Milovancev, M., Muir, P., Manley, P.A., Seeherman, H.J., and Schaefer, S. Clinical application of recombinant human bone morphogenetic protein-2 in 4 dogs. Vet Surg 36, 132, 2007.
23. Wikesjo, U.M., Huang, Y.H., Polimeni, G., and Qahash, M. Bone morphogenetic proteins: a realistic alternative to bone grafting for alveolar reconstruction. Oral Maxillofac Surg Clin North Am 19, 535, vi-vii, 2007.
24. Toriumi, D.M., Kotler, H.S., Luxenberg, D.P., Holtrop, M.E., and Wang, E.A. Mandibular reconstruction with a recombinant bone-inducing factor-functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 117, 1101, 1991.
25. Boyne, P.J. Animal studies of the application of rhBMP-2 in maxillofacial reconstruction. Bone 19, S83, 1996.
26. Boyne, P.J. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 83-A Suppl 1, S146, 2001.
27. Seto, I., Tachikawa, N., Mori, M., Hoshino, S., Marukawa, E., Asahina, I., et al. Restoration of occlusal function using osseointegrated implants in the canine mandible reconstructed by rhBMP-2. Clin Oral Implant Res 13, 536, 2002.
28. Gautschi, O.P., Frey, S.P., and Zellweger, R. Bone morphogenetic proteins in clinical applications. Anz J Surg 77, 626, 2007.
29. Bostrom, M.P.G., and Camacho, N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res S274, 1998.
30. Kujala, S., Raatikainen, T., Ryhanen, J., Kaarela, O., and Jalovaara, P. Composite implant of native bovine bone morphogenetic protein (BMP) and biocoral in the treatment of scaphoid nonunions-a preliminary study. Scand J Surg 91, 186, 2002.
31. Dwek, J.R. The periosteum: what is it, where is it, and what mimics it in its absence? Skeletal Radiol 39, 319, 2010.
32. Lu, C.Y., Huang, S., Miclau, T., Helms, J.A., and Colnot, C. Mepe is expressed during skeletal development and regeneration. Histochem Cell Biol 121, 493, 2004.
33. Bouletreau, P.J., Warren, S.M., Spector, J.A., Peled, Z.M., Gerrets, R.P., Greenwald, J.A., et al. Hypoxia and VEGF upregulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109, 2384, 2002.
34. Guillotin, B., Bareille, R., Bourget, C., Bordenave, L., and Amedee, J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic, function. Bone 42, 1080, 2008.
35. Colnot, C., Lu,C.Y., Hu,D., andHelms, J.A.Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol 269, 55, 2004.
36. Panetta, N.J., Gupta, D.M., Lee, J.K., Wan, D.C., Commons, G.W., and Longaker, M.T. Human adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiation. Plast Reconstr Surg 125, 483, 2010.
37. Carano, R.A.D., and Filvaroff, E.H. Angiogenesis and bone repair. Drug Discov Today 8, 980, 2003.
38. Peng, H.R., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
39. Deckers, M.M.L., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van der Bent, C., Papapoulos, S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
40. Salyer, K.E., Gendler, E., and Squier, C.A. Long-term outcome of extensive skull reconstruction using demineralized perforated bone in Siamese twins joined at the skull vertex. Plast Reconstr Surg 99, 1721, 1997.
41. Salyer, K.E., Gendler, E., Menendez, J.L., Simon, T.R., Kelly, K.M., and Bardach, J. Demineralized perforated bone implants in craniofacial surgery. J Craniofac Surg 3, 55, 1992.